Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 3
2000 4
2001 3
2002 6
2003 3
2004 3
2005 2
2006 3
2007 5
2008 8
2009 8
2010 9
2011 7
2012 8
2013 8
2014 14
2015 12
2016 11
2017 9
2018 13
2019 19
2020 14
2021 19
2022 9
2023 15
2024 20
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Results by year

Filters applied: . Clear all
Page 1
Molecular and clinical diversity in primary central nervous system lymphoma.
Hernández-Verdin I, Kirasic E, Wienand K, Mokhtari K, Eimer S, Loiseau H, Rousseau A, Paillassa J, Ahle G, Lerintiu F, Uro-Coste E, Oberic L, Figarella-Branger D, Chinot O, Gauchotte G, Taillandier L, Marolleau JP, Polivka M, Adam C, Ursu R, Schmitt A, Barillot N, Nichelli L, Lozano-Sánchez F, Ibañez-Juliá MJ, Peyre M, Mathon B, Abada Y, Charlotte F, Davi F, Stewart C, de Reyniès A, Choquet S, Soussain C, Houillier C, Chapuy B, Hoang-Xuan K, Alentorn A. Hernández-Verdin I, et al. Among authors: uro coste e. Ann Oncol. 2023 Feb;34(2):186-199. doi: 10.1016/j.annonc.2022.11.002. Epub 2022 Nov 17. Ann Oncol. 2023. PMID: 36402300 Free article.
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Alhalabi KT, Stichel D, Sievers P, Peterziel H, Sommerkamp AC, Sturm D, Wittmann A, Sill M, Jäger N, Beck P, Pajtler KW, Snuderl M, Jour G, Delorenzo M, Martin AM, Levy A, Dalvi N, Hansford JR, Gottardo NG, Uro-Coste E, Maurage CA, Godfraind C, Vandenbos F, Pietsch T, Kramm C, Filippidou M, Kattamis A, Jones C, Øra I, Mikkelsen TS, Zapotocky M, Sumerauer D, Scheie D, McCabe M, Wesseling P, Tops BBJ, Kranendonk MEG, Karajannis MA, Bouvier N, Papaemmanuil E, Dohmen H, Acker T, von Hoff K, Schmid S, Miele E, Filipski K, Kitanovski L, Krskova L, Gojo J, Haberler C, Alvaro F, Ecker J, Selt F, Milde T, Witt O, Oehme I, Kool M, von Deimling A, Korshunov A, Pfister SM, Sahm F, Jones DTW. Alhalabi KT, et al. Among authors: uro coste e. Acta Neuropathol. 2021 Nov;142(5):841-857. doi: 10.1007/s00401-021-02354-8. Epub 2021 Aug 21. Acta Neuropathol. 2021. PMID: 34417833 Free PMC article.
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A, Marie Y, Mokhtari K, Tabouret E, Trabelsi N, Uro-Coste E, Delattre JY, Figarella-Branger D; POLA Network. Appay R, et al. Among authors: uro coste e. Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124. Neuro Oncol. 2019. PMID: 31832685 Free PMC article.
[Large scale teaching in pathology].
Bertheau P, Denize T, Calvani J, Gardair C, Jacquier A, Razafimahefa J, Eymerit-Morin C, Perron É, Tremblay-Le May R, Borduas M, Pote N, Battistella M, Badoual C, Fléjou JF, Leteurtre E, Uro-Coste E, Buob D, Valmary-Degano S. Bertheau P, et al. Among authors: uro coste e. Ann Pathol. 2019 Apr;39(2):144-150. doi: 10.1016/j.annpat.2018.12.009. Epub 2019 Jan 30. Ann Pathol. 2019. PMID: 30711337 Review. French.
Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Pouessel D, Ken S, Gouaze-Andersson V, Piram L, Mervoyer A, Larrieu-Ciron D, Cabarrou B, Lusque A, Robert M, Frenel JS, Uro-Coste E, Olivier P, Mounier M, Sabatini U, Sanchez EH, Zouitine M, Berjaoui A, Cohen-Jonathan Moyal E. Pouessel D, et al. Among authors: uro coste e. Oncologist. 2023 Sep 7;28(9):825-e817. doi: 10.1093/oncolo/oyad095. Oncologist. 2023. PMID: 37196069 Free PMC article. Clinical Trial.
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
Tauziède-Espariat A, Uro-Coste E, Sievers P, Nicaise Y, Mariet C, Siegfried A, Pierron G, Guillemot D, Benzakoun J, Pallud J, Roques M, Bonneville F, Larrieu-Ciron D, Chaynes P, Saffroy R, Hamelin J, Hasty L, Métais A, Chrétien F, Kool M, Gojo J, Varlet P; RENOCLIP-LOC. Tauziède-Espariat A, et al. Among authors: uro coste e. Acta Neuropathol Commun. 2023 Feb 13;11(1):26. doi: 10.1186/s40478-023-01523-y. Acta Neuropathol Commun. 2023. PMID: 36782314 Free PMC article. Review.
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
Appay R, Bielle F, Sievers P, Barets D, Fina F, Boutonnat J, Adam C, Gauchotte G, Godfraind C, Lhermitte B, Maurage CA, Meyronet D, Mokhtari K, Rousseau A, Tauziède-Espariat A, Tortel MC, Uro-Coste E, Burel-Vandenbos F, Chotard G, Pesce F, Varlet P, Colin C, Figarella-Branger D. Appay R, et al. Among authors: uro coste e. Neuropathol Appl Neurobiol. 2022 Aug;48(5):e12813. doi: 10.1111/nan.12813. Epub 2022 Mar 23. Neuropathol Appl Neurobiol. 2022. PMID: 35293634
Muscular phenotype description of abnormal THOC2 splicing.
Dubucs C, Rendu J, Michel-Calemard L, Menassa R, Langeois M, Nicaise Y, Ousselin J, Aziza J, Uro-Coste E. Dubucs C, et al. Among authors: uro coste e. Neuromuscul Disord. 2023 Dec;33(12):978-982. doi: 10.1016/j.nmd.2023.09.009. Epub 2023 Oct 5. Neuromuscul Disord. 2023. PMID: 37945483
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status.
Tauziède-Espariat A, Uro-Coste E, Nicaise Y, Sievers P, von Deimling A, Sahm F, Aboubakr O, Métais A, Chrétien F, Varlet P. Tauziède-Espariat A, et al. Among authors: uro coste e. Acta Neuropathol Commun. 2023 Oct 24;11(1):170. doi: 10.1186/s40478-023-01667-x. Acta Neuropathol Commun. 2023. PMID: 37875973 Free PMC article. No abstract available.
Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.
Depond CC, Zouaoui S, Darlix A, Rigau V, Mathieu-Daudé H, Bauchet F, Khettab M, Trétarre B, Figarella-Branger D, Taillandier L, Boetto J, Pallud J, Zemmoura I, Roche PH, Bauchet L; French Brain Tumour DataBase (FBTDB) Participants, Investigators with the participation of the Société française de neurochirurgie (SFNC); Club de neuro-oncologie de la société française de neurochirurgie, Société française de neuropathologie (SFNP); Association des neuro-oncologues d’expression française (ANOCEF). Depond CC, et al. Acta Neurochir (Wien). 2024 May 14;166(1):214. doi: 10.1007/s00701-024-06093-z. Acta Neurochir (Wien). 2024. PMID: 38740641
204 results